MarketResearchReports.Biz announces addition of new report “Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018” to its database
Albany, NY -- (SBWIRE) -- 05/21/2013 -- MarketResearchReports.Biz announces addition of new report “Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018” to its database
Teleradiology involves the transmission of digital medical images from x-ray tests, sonograms, CAT scans etc. over an electronically controlled network for diagnostic purposes. The global teleradiology technology market is expected to exhibit a healthy growth rate during the forecasted period. The healthy growth rate of the market is accounted for by growth drivers such as technological advancements in the field of remote patient diagnosis, rising demand for medical tourism, and growing number of manufacturers providing mobile healthcare services. The Asia-Pacific market will fuel the expansion of the global market due to the future opportunities owing to the economical growth of nations such as China and India.
To Read The Complete Report with TOC: www.marketresearchreports.biz/analysis-details/teleradiology-technology-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The market is segmented on the basis of applications into hospitals, healthcare diagnostic centers, and home healthcare. North America, Europe, Asia-Pacific and the rest of the world regions form the market segmentation on the basis of geography. The North American region was valued as the largest market in terms of market share in 2011 followed by Europe. The Asia-Pacific region is expected to exhibit the fastest CAGR from 2012 to 2018.
Some of the key players in the market are Teleradiology Solutions Pvt. Ltd., Agfa-Gevaert NV, Sectra Imtec AB, NightHawk Radiology Holdings Inc. and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/167886
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Therapeutic Vaccines Market - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 – 2018: http://www.marketresearchreports.biz/analysis/167887
Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and developm...